Oct 2026· Hematology/Oncology Clinics of North America· Vol 40 5, pp.
857-873
· 0 citations· 95 references
Medicine
TL;DR
With breakthrough findings in such a relatively short period of time, the treatment of patients with metastatic melanoma has become intensely personalized.
Abstract
There has been perhaps no greater advance in the prognosis of solid tumors in the last decade than for patients with metastatic melanoma. This is due to significant improvements in treatment based on two key components of melanoma tumor biology (1) the identification of driver mutations with therapeutic potential and (2) the mechanistic understanding of a tumor-specific immune response. With breakthrough findings in such a relatively short period of time, the treatment of patients with metastatic melanoma has become intensely personalized.
Outcomes for patients with breast cancer have improved over time due to increased screening and the availability of more effective therapies. It is important to recognize that breast cancer is a heterogeneous disease that requires treatment based on molecular characteristics. Early endpoints such as pathologic complete...
A. Abbasi, Vincent Wu, J. Lang et al.· Hematology/Oncology Clinics...· 0 citations
In-transit melanoma metastases are defined as deposits of tumor cells in the cutaneous and/or subcutaneous planes occurring between the primary melanoma and the regional lymph node. They may be present at diagnosis or develop as recurrences in 5%-10% of patients, and their presence has been associated with an adverse p...
V. Alfaro-Fierro, C. Retamal-Altbir, P. Vargas-Mora· Actas Dermo-Sifiliográficas· 0 citations
Pediatric precision oncology has provided a greater understanding of the wide range of molecular alterations in difficult-to-treat or rare tumors with the aims of increasing survival as well as decreasing toxicity and morbidity from current cytotoxic therapies. In this article, the authors discuss the current state of...
William G. Lee, Eugene S. Kim· Hematology/Oncology Clinics...· 0 citations
Simple Summary Melanoma is a serious skin cancer, and in East Asian patients it frequently arises at acral sites or on internal mucosal surfaces rather than on sun-exposed skin. These forms tend to respond less well to immunotherapy, the current standard first-line treatment, yet it remains unclear which tumors benefit...
Seo Yoon Jang, Minsuk Kwon, Jeeyun Lee et al.· Cancers· 0 citations
Simple Summary This study was undertaken to evaluate the current role of adjuvant radiotherapy after surgery for macrometastatic melanoma and to identify clinical situations in which it may still provide benefit. We found that adjuvant radiotherapy is now used infrequently but can be safely combined with modern systemi...
Magdalena Fischer, S. Gerum, F. Roeder et al.· Cancers· 0 citations
Robust long‐term survival data have transformed the prognosis of metastatic melanoma. For combination therapy with immune checkpoint inhibitors (ICIs), 10‐year melanoma‐specific survival rates now exceed 50 %, and durable disease control is achievable in a substantial proportion of patients, including those with brain...
Markus Reitmajer, S. Dugas-Breit, C. Blomen et al.· Journal der Deutschen Dermat...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
